In brief, our research group presents multicancer analysis of HMGB1 combined with the study of clinical survival prognosis, methylated DNA, phosphorylated proteins, tumor-infiltrating immune cells, TMB, and MSI in different tumors. This evidence concerns the gene HMGB1 and neoplasm.